European Association of Nuclear Medicine (EANM)’s Post

Nuclear medicine plays a vital role in patient care by supporting the diagnosis, management, and treatment of serious diseases. Through non-invasive imaging, nuclear medicine provides functional insights at the molecular and cellular level by tracking the uptake and metabolism of radiotracers in tissues. What makes this field so powerful is its ability to detect abnormalities early in the disease process, often before they are visible with other diagnostic tools. This early detection offers patients a better chance at timely treatment and improved outcomes. Nuclear medicine is at the forefront of precision medicine, providing essential tools for designing individualized treatments tailored to a patient’s genetic profile. A rapidly evolving area in this field is Theranostics, which combines diagnosis and therapy, allowing clinicians to 'see what you treat and treat what you see.' This approach uses diagnostic tools to identify disease and then treats it with the same or similar methods, maximizing therapeutic effectiveness while minimizing toxicity. Currently, Theranostics is making significant strides in treating thyroid, prostate, and neuroendocrine cancers.

Happy Nuclear Medicine Week from SNMMI! Our Technologist Section President, Julie Bolin, MS, CNMT, FSNMMI-TS, talks about just how far nuclear medicine has come from the early days of treating thyroid cancer. (All the way back in the 1940s!) Today with the prominence of theranostics, nuclear medicine has the amazing potential to both detect and treat diseases like never before. Of course, all of this is thanks to the nuclear medicine professionals who work hard to specialize in this field, provide the highest quality of patient care, and who never stop researching and innovating to push our field forward. Here's to all of you! Don't forget to share your Nuclear Medicine Week pictures with us throughout the week. Take a pic in your merch or in your workplace and tag us @snm_mi and use #NUCMEDWEEK2024. More info on how nuclear medicine is revolutionizing healthcare: https://lnkd.in/e3x2KQxt

Enhanced my expertise in nuclear medicine by attending the Conference on Application of Radioisotopes as Nuclear Medicine, sponsored by Atomic Energy Regulatory Board. Key takeaways: - Novel radioisotope applications - Advances in cancer treatment - Imaging innovations - Collaborative research opportunities Looking forward to applying these insights! #NuclearMedicine #Radioisotopes #ProfessionalDevelopment #ContinuingEducation #Healthcare #lnctindore #oxfordinternationalcollege

The 9th International Symposium on MEdical RADioisotopes (#ISMERAD2024) takes place on 26th of April 2024 in Ghent (NH Belfort). The main focus of this edition is on Alpha Therapy: New Approaches in Radionuclide Therapy. https://lnkd.in/end-VWEh Our goal is to: • Provide information on the perspectives of the world production of medical radioisotopes during the years to come; • Discuss challenges of the transport and distribution processes including safety, security, transparency and prompt delivery; • Present breakthroughs in radiopharmacy and nuclear medicine; • Introduce new industrial and research initiatives. Registration for the symposium is mandatory: https://lnkd.in/eYBgYNV5 #ISMERAD #MedicalRadioisotopes #AlphaTherapy #RadioisotopesSupplyChain

Research and Innovation from China is significantly contributing to the advancement of Nuclear Medicine. Check out 2024 JNM Supplement 1. The Journal of Nuclear Medicine - JNM Johannes Czernin Weibo Cai Kuangyu Shi Wolfgang Weber

⚛️ Nuclear Medicine and Molecular Imaging Week is Celebrated the first full week of October. In commemoration of this event, please find the following trivia questions and answers about the profession below. QUESTIONS (1) What was the first recorded medical (clinical) use of radiotracers? (2) What is the name of the flagship journal for nuclear medicine technologists? (3) What was the name of the Society of Nuclear Medicine and Molecular Imaging before 2012? (4) According to the 2023 US Bureau of Labor Statistics report, how many employed nuclear medicine technologists are there in the U.S.? ANSWERS: (1a) The first recorded procedure was to measure concentrations of substance in the body. (2a) Journal of Nuclear Medicine Technology. (3a) SNMMI name in 2012 = Society of Nuclear Medicine. (4a) The number of employed NMT professionals, according to the Bureau of Labor and Statistics, is 16,560. GURNICK.EDU #GurnickAcademy #NucMed #SNMMI24 #theranostics #NUCMEDWEEK2024 #NMW2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI)

📑 PUBLICATION Why are medical students shying away from #nuclearmedicine, despite its cutting-edge technology and critical role in #patientcare? Our latest article "Why do medical students decide not to get trained in the most appealing speciality, nuclear medicine?" dives into the factors influencing their decisions, what this means for the future of #healthcare and the implications for the healthcare #industry. Discover the untold story behind the most intriguing speciality in medicine. Read more here : https://lnkd.in/dxJsGzJX An initiative of the Nuclear Medicine Europe Communications Working Group #MedicalEducation #FutureOfMedicine

We are happy to promote another freshly published article, titled 'A scoping review of person-centred care strategies used in diagnostic Nuclear Medicine'. Many thanks to the EANM Technologists Committee for the hard work, and to the EFRS European Federation of Radiographer Societies for working on this paper with us. Read it now! ➡ https://lnkd.in/dadJTiAY #EANM #Publications #NuclearMedicine #Technologists

Belgium’s nuclear medicine expertise resonates worldwide 🤝 The Belgian nuclear research centre SCK CEN reports its collaboration with the US-based SpectronRx, specialized in radioactive cancer treatments, is becoming more concrete. 🥼 Completion of the latter’s first European facility in Mol, Belgium, is scheduled for November 2024, with both organisations currently preparing laboratories and other infrastructure. 💡 The facility will focus on the process of radiolabeling: the coupling of actinium -225 to a vector which directs it to the cancer cells. 🌐 The development is testimony of Belgium’s position as a veritable hub in nuclear medicine, and is complementary with the production of actinium -225 by PANTERA, another partnership of SCK CEN with particle accelerator technology specialist IBA. #Belgium #EmbracingOpenness #nuclearmedicine #actinium225 #cancertreatment #radiolabeling #openforpartnerships

🚀 Sharing radiopharmaceutical insights 🚀 Radiopharmaceuticals are an emerging and innovative therapeutic class in the anti-cancer market. Recently, Federico Mambretti, the Country President at Novartis Belux, recognized this potential and visited the renowned Belgian radiopharmaceutical research center SCK CEN. In this video, Prof. Sarah Baatout, Deputy Institute Director Nuclear Medical Applications, explains the importance of radiopharmaceuticals. We, ZTI, are also developing cutting-edge radiopharmaceuticals. In line with Novartis's interest, we would like to share insights about RLT, a specific type of radiopharmaceutical that has been garnering attention. #Novartis #SCKCEN #RLT #Radiopharmaceuticals #Cancer #ODD #ADC #Antibody #RadioAntibodyConjugate #RAC #Nanotech #DDS #Platform #alphatherapy #FDA #IND and #ZTIBIOSCIENCES 🌐